Advanced Solid Cancer
17 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of SHR-A1904 in Patients With Advanced Solid Cancer (NCT04877717) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-07-01 |
| A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor (NCT03791112) | Betta Pharmaceuticals Co., Ltd. | 2019-07-18 |
| Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer (NCT03884517) | Bio-Thera Solutions | 2019-03-15 |
| Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer (NCT03618043) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2018-09-13 |
| A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies (NCT01416623) | Jiangsu HengRui Medicine Co., Ltd. | 2010-09-01 |
Track Advanced Solid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.